MCAP — MedCap AB (publ) Income Statement

0.000.00%

Last trade - 00:00

FinancialsSpeculativeMid CapHigh Flyer

Annual income statement for MedCap AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	817	916	1,111	1,587	1,807
Cost of Revenue
Gross Profit	366	457	529	738	1,057
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	728	789	940	1,360	1,534
Operating Profit	89.1	127	171	228	272
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	81.5	117	152	222	262
Provision for Income Taxes
Net Income After Taxes	64.5	98.1	118	173	209
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	60.9	96.5	118	172	207
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	60.9	96.5	118	172	207
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	4.37	6.52	8.07	12	14.4
Dividends per Share